Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

NCT04064905 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Zika Virus

Interventions

BIOLOGICAL: mRNA-1893
OTHER: Placebo

Sponsor

ModernaTX, Inc.

Collaborators

[object Object]